Lorenzo Falchi

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Hodgkin Lymphoma

Histone Deacetylase

Top Venues

Leukemia & lymphoma

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Blood cancer journal

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin Parsons, Paolo F Caimi, Ian W Flinn, Alex F Herrera, Jeffrey Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy. Blood 143 (16) (2024)
Lindsey Elizabeth Roeker, Tatyana A Feldman, Jacob D Soumerai, Victoria Falco, Gail Panton, Colleen Dorsey, Andrew D Zelenetz, Lorenzo Falchi, Jae H Park, David J Straus, Camila Pena Velasquez, Sonia Lebowitz, Yehudit Fox, Kristen Battiato, Carissa Laudati, Meghan C Thompson, Elizabeth McCarthy, Sabrina Kdiry, Rosalba Martignetti, Teja Turpuseema, Michelle Purdom, Dana Paskalis, Hari P Miskin, Peter Sportelli, Lori A Leslie, Anthony R Mato
Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (18) (2022)
Fushen Sha, Michelle Okwali, Anna Alperovich, Philip C Caron, Lorenzo Falchi, Audrey Hamilton, Paul A Hamlin, Steven M Horwitz, Erel Joffe, Niloufer Khan, Anita Kumar, Matthew J Matasar, Alison J Moskowitz, Ariela Noy, Colette Owens, Maria Lia Palomba, Ildefonso Rodriguez-Rivera, David Straus, Gottfried von Keudell, Andrew D Zelenetz, Joachim Yahalom, Ahmet Dogan, Heiko Schöder, Venkatraman E Seshan, Gilles Andre Salles, Anas Younes, Connie Lee Batlevi
Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma. Blood cancer journal 12 (2) (2022)
Eric Mou, Lorenzo Falchi, Vandana Sundaram, Jeremy S Abramson, Ronald Balassanian, Sara Beygi, Megan J Fitzpatrick, Annabel Kate Frank, Srishti Gupta, Oscar Lin, Joshua R Reed, Steven R Long, Amy Ly, Joshua R Menke, Daniel R Reed, Roberto Ruiz-Cordero, Ashley K Volaric, Yi Xie, Linlin Wang, Kwun Wah Wen, Sara L Zadeh, Yasodha Natkunam, Matthew C Cheung, Dita A Gratzinger, null null
Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation. Leukemia & lymphoma 62 (12) (2021)
Luigi Scotto, Cristina Kinahan, Eugene Douglass, Changchun Deng, Maryam Safari, Beatrice Casadei, Enrica Marchi, Jennifer Kimberly Lue, Francesca Montanari, Lorenzo Falchi, Changhong Qiao, Nandakumar Renu, Susan E Bates, Andrea Califano, Owen A O'Connor
Targeting the T-Cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune-Modulatory Signaling Pathways. Molecular cancer therapeutics 20 (8) (2021)
Alison J Moskowitz, Gunjan Shah, Heiko Schöder, Nivetha Ganesan, Esther Drill, Helen Hancock, Theresa Davey, Leslie Perez, Sunyoung Ryu, Samia Sohail, Alayna Santarosa, Natasha Galasso, Rachel Neuman, Brielle Liotta, William Blouin, Anita Kumar, Oscar B Lahoud, Connie Lee Batlevi, Paul Hamlin, David J Straus, Ildefonso Rodriguez-Rivera, Colette Owens, Philip Caron, Andrew M Intlekofer, Audrey Hamilton, Steven M Horwitz, Lorenzo Falchi, Erel Joffe, William T Johnson, Christina Lee, Maria Lia Palomba, Ariela Noy, Matthew J Matasar, Georgios Pongas, Gilles Andre Salles, Santosha A Vardhana, Beatriz Wills Sanin, Gottfried von Keudell, Joachim Yahalom, Ahmet Dogan, Andrew D Zelenetz, Craig H Moskowitz
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (28) (2021)
Lorenzo Falchi, Filiz Sen
18 FDG-avid cholesterol granuloma mimicking residual aggressive lymphoma after chemotherapy. EJHaem 3 (1) (2021)